Financial News
All News about Beam Therapeutics Inc
![](https://g.foolcdn.com/editorial/images/739767/healthcare.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/biopharma-1600.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230629144751_verve-therapeutics-gains-20.jpg)
![](https://g.foolcdn.com/editorial/images/735895/dna-on-monitor-scientists.jpg)
![](https://g.foolcdn.com/editorial/images/733047/scientists-examine-cell-make-up-microscope-biotech.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1789.jpeg?width=1200&height=800&fit=crop)
Beam Therapeutics: Q1 Earnings Insights
May 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Beam Therapeutics Stands With Analysts
March 21, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Beam Therapeutics Stands With Analysts
March 01, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/731107/dna-on-monitor-scientists.jpg)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/03/cathie-wood-stocks-1600.png)
![](https://g.foolcdn.com/editorial/images/730177/dna-on-monitor-scientists.jpg)
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Tesla_Photo_by_Roschetzky_Photography_on_Shutterstock_4.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2023/01/stocks-to-watch-chart-businessman-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/growthstocks_1600_02.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/ARK_Photo_by_Ira_Lichi_on_Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/02/dna-helix.png)
![](https://g.foolcdn.com/editorial/images/723147/dna-on-monitor-scientists.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-min-1.jpg)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.